대한부인종양연구회 KGOG 2022 Semi-annual Meeting : 2022-05-14
교육일자 : 2022-05-14
교육장소 : Bexco  
교육주제 : KGOG 2022 Semi-annual Meeting
주최기관 : 대한부인종양학회
시행기관(지부/과) : 대한부인종양연구회  
담당자 : 김인숙
연락처 : 02-512-5420  
이메일 : kiskgog@hanmail.net      
교육종류 : 산부인과      
참석예상인원 : 150명
희망평점 : 6점  
지역 : 부산광역시
교육시간 : 7 시간 11분  
세부수강료 : 50,000원      
비고       

구분 월일 강의실 시간 교육제목  강사명(소속) 필수과목
교육시간 05-14 제1전시실 3층회의장 08:30~08:35 Ovary, Introduction/Review of on-going studies  강석범(국립암센터) 
교육시간 05-14 제1전시실 3층회의장 08:35~08:39 Phase III randomized clinical trial for stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (KGOG 3062 OV-HIPEC2)  임명철(국립암센터) 
교육시간 05-14 제1전시실 3층회의장 08:39~08:43 Niraparib with or without bevacizumab in maintenance after complete cytoreduction in patients with ovarian cancer ( KGOG 3063 NIRVANA-1)  임명철(국립암센터) 
교육시간 05-14 제1전시실 3층회의장 08:43~08:51 Phase II trial evaluation the Efficacy and safety of physician chosen Chemotherapy  이방현(인하대병원) 
교육시간 05-14 제1전시실 3층회의장 08:51~09:21 A Phase 3 multicenter study on the additional effect of stereotactic body radiation  김용배(세브란스병원) 
토론 05-14 제1전시실 3층회의장 09:21~09:31 discussion  김미경(이대목동병원) 
교육시간 05-14 제1전시실 3층회의장 09:31~10:01 Fatal toxicity of PARPi maintenance of ovarian cancer: How do we offer appropriate monitoring and investigation?  정기선(양산부산대병원) 
교육시간 05-14 제1전시실 3층회의장 10:20~10:23 Cervix, Vulva, Vagina Committee-Introduction  이근호(서울성모병원) 
교육시간 05-14 제1전시실 3층회의장 10:23~10:28 Overview of ongoing study  정용욱(강남차병원) 
교육시간 05-14 제1전시실 3층회의장 10:28~10:33 KGOG1043/A randomized, open-label phase 3 trial of Tisotumab vedotin Vs. investigator’s choice chemotherapy in second or third line recurrent or metastatic cervical cancer  이성종(서울성모병원) 
교육시간 05-14 제1전시실 3층회의장 10:33~10:38 KGOG1044/Feasibility of HPV DNA and vaginal infectious disease detection in mail-delivered self obtained vaginal sample obtained by G+kit (SELPAX-I)  김문홍(원자력병원) 
교육시간 05-14 제1전시실 3층회의장 10:38~10:43 KGOG1046/Adjuvant chemotherapy versus radiotherapy for postoperative cervical cancer: A phase 3 trial (AFTER)  심승혁(건국대병원) 
교육시간 05-14 제1전시실 3층회의장 10:43~10:48 KGOG1047/Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr. A phase III, randomized controlledclinical trial (DEBULK trial)  노주원(일산차병원) 
교육시간 05-14 제1전시실 3층회의장 10:48~11:03 Special Lecture I : Consideration when conduct clinical trials of gynecologic cancer as  TBD() 
토론 05-14 제1전시실 3층회의장 11:03~11:05 discussion  윤보성(일산차병원) 
교육시간 05-14 제1전시실 3층회의장 11:05~11:15 COnization Before minimally invasive RAdical hysterectomy in 2018 FIGO stage IB1 cervical cancer (COBRA-1)  이마리아(서울대병원) 
토론 05-14 제1전시실 3층회의장 11:15~11:20 discussion  백지흠(아주대병원) 
교육시간 05-14 제1전시실 3층회의장 11:20~11:30 The comparison of proportion of positive resection margin by use of Lugol’s solution during LEEP and the identifications of predictors for residual tumor: A phase III, randomized controlled trial (Lugol trial)  노주원(일산차병원) 
토론 05-14 제1전시실 3층회의장 11:30~11:35 discussion  조상현(서울성모병원) 
교육시간 05-14 제1전시실 3층회의장 11:35~12:05 Special Lecture II : Introduction of Silva Pattern in Endocervical Adenocarcinoma as an important determinant for pelvic lymph node dissection  김규래(서울아산병원) 
교육시간 05-14 제1전시실 3층회의장 12:10~12:20 20 years history of KGOG  민경진(고대안산병원) 
교육시간 05-14 제1전시실 3층회의장 12:20~12:30 Renewal homepage of KGOG  송재윤(고대안암병원) 
교육시간 05-14 제1전시실 3층회의장 12:30~12:50 Cutting-edge front-line maintenance therapy in BRCAm ovarian cancer – SOLO-1  백이선(강북삼성병원) 
교육시간 05-14 제1전시실 3층회의장 12:50~13:10 The Era of precision medicine with Olaparib and bevacizumab as frontline maintenance  심승혁(건국대병원) 
토론 05-14 제1전시실 3층회의장 13:10~13:20 Discussion  () 
교육시간 05-14 제1전시실 3층회의장 13:30~13:31 Surgery Committee-Introduction  이은주(중앙대병원) 
교육시간 05-14 제1전시실 3층회의장 13:31~13:36 KGOG 4004 (OVsurg-2102-1): A survey on peritonectomy procedure in debulking operation of advanced ovarian, fallopian, peritoneal cancer  김명선(성빈센트병원) 
교육시간 05-14 제1전시실 3층회의장 13:36~13:41 KGOG 4005 (OVsurg-2101): The analysis of the patients who have received reoperation whining 30 days after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer  임명철(국립암센터) 
교육시간 05-14 제1전시실 3층회의장 13:41~13:45 OVsurg-2103: The analysis of 90-day postoperative mortality after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer  송용중(양산부산대병원) 
교육시간 05-14 제1전시실 3층회의장 13:45~13:50 OVsurg-2108: Assessment of QoL after LAR or visceral peritoneal stripping during cytoreductive surgery for AEOC: prospective cohort study (LAPSODY) trial  박수진(서울대병원) 
교육시간 05-14 제1전시실 3층회의장 13:50~13:55 OVsurg-2106: Selection Criteria for Omitting Interval debulking surgery after neoadjuvant chemotherapy for high grade serous carcinoma of the ovary (SCORE study)  이유영(삼성서울병원) 
토론 05-14 제1전시실 3층회의장 13:55~14:00 discussion  () 
교육시간 05-14 제1전시실 3층회의장 14:00~14:05 Surgical Treatment of lymphedema  이준석(경북대병원성형외과) 
토론 05-14 제1전시실 3층회의장 14:05~14:10 discussion  () 
교육시간 05-14 제1전시실 3층회의장 14:30~14:33 Rare Tumor Committee-Introduction  최철훈(삼성서울병원) 
교육시간 05-14 제1전시실 3층회의장 14:33~14:53 Stratified mucin-producing intraepithelial lesion (SMILE) and invasive stratified mucin  김현수(삼성서울병원) 
교육시간 05-14 제1전시실 3층회의장 14:53~14:58 Optimized therapeutic strategy for recurrent ovarian clear cell carcinoma with ARID1A status (OTC)  김태은(분당서울대병원) 
교육시간 05-14 제1전시실 3층회의장 14:58~15:03 Clinical characteristics and prognosis in HPV independent cervical adenocarcinoma  장하균(고대안산병원) 
교육시간 05-14 제1전시실 3층회의장 15:03~15:08 Radical vs. fertility sparing surgery in intraepithelial mucinous carcinoma of ovary  심승혁(건국대병원) 
교육시간 05-14 제1전시실 3층회의장 15:08~15:10 MIS vs. open surgery in rare histology cervical cancer  김세익(서울대병원) 
교육시간 05-14 제1전시실 3층회의장 15:10~15:12 A MRI-based machine learning approach for distinguishing uterine sarcoma leiomyomas  김태훈(보라매병원) 
교육시간 05-14 제1전시실 3층회의장 15:12~15:14 BRCA status in epithelial ovarian cancer with other than serous and endometrioid adenocarcinoma  김태훈(보라매병원) 
교육시간 05-14 제1전시실 3층회의장 15:14~15:19 Accuracy of cytology (PAP) in HPV independent cervical cancer  장지선(삼성서울병원) 
토론 05-14 제1전시실 3층회의장 15:19~15:24 discussion  () 
교육시간 05-14 제1전시실 3층회의장 15:40~15:41 Uterine corpus-GTT committee introduction  김민규(삼성창원병원) 
교육시간 05-14 제1전시실 3층회의장 15:41~15:46 Review of ongoing study Active: 2020,2021(TREE PRO),2022(NRG GY018),  이마리아(서울대병원) 
교육시간 05-14 제1전시실 3층회의장 15:46~15:51 Progress of proposed studies  이마리아(서울대병원) 
교육시간 05-14 제1전시실 3층회의장 15:51~15:56 : Radical hysterectomy in Endometrial cancer with Cervical involvemENT (RECENT)  김성민(일산차병원) 
교육시간 05-14 제1전시실 3층회의장 15:56~16:01 Characteristics, risk factors, and prognosis of incidentally diagnosed uterine neoplasms: a multi-institutional review study  백민현(한림대성심병원) 
교육시간 05-14 제1전시실 3층회의장 16:01~16:06 : Prevalence and clinical characteristics of endometrial cancer by molecular classification in Korean patients  한관희(강동경희대병원) 
교육시간 05-14 제1전시실 3층회의장 16:06~16:11 Integrated genomic characterization of advanced endometrial cancer: KGOG consortium study  김미경(이대목동병원) 
교육시간 05-14 제1전시실 3층회의장 16:11~16:31 Androgen therapy Clinical Trial for Uterine Cancer  Katherine Kurnit(University of Chicago) 
교육시간 05-14 제1전시실 3층회의장 16:31~16:51 Clinical Trial Suggestion for Gestational Trophoblastic Neoplasia  Neil S. Horowitz(Brigham & Women’s Hospital/Dana Faber Cancer Institute)